In this episode, we talk to Jason Downing, an expert in mRNA technology, about the transformative potential of biotech in addressing the world’s most pressing health challenges. We explore how mRNA therapeutics can target diseases like cystic fibrosis and sickle cell, and even reverse aging. Jason shares his insights into the rapidly advancing field, where scalable and customizable treatments could soon be the new norm in healthcare. (0:00) Introduction and guest Jason Downing background (1:06) The rise of RNA therapeutics and mRNA vaccines (6:24) The potential and future of mRNA technology (11:33) Predictions for mRNA technology in the next 5 years (16:06) Inside the development of mRNA vaccines (18:15) Closing remarks on mRNA's impact on society (19:14) Subscribe and support (19:28) Sponsor: Vala AI advertisement
Informations
- Émission
- FréquenceChaque semaine
- Publiée20 août 2024 à 12:00 UTC
- Durée20 min
- Saison2
- Épisode38
- ClassificationTous publics